GlaxoSmithKline Gets 115 Avandia Injury Cases Dismissed
A Pennsylvania district judge dismissed 115 out of 117 cases that GlaxoSmithKline LLC argued were outside the statute of limitations in the multidistrict litigation over injuries caused by diabetes drug Avandia,...To view the full article, register now.
Already a subscriber? Click here to view full article